Far Infrared Therapy for Lyme Disease
A Comprehensive Review
Introduction
Chronic Lyme disease presents multiple challenges for patients and practitioners alike. As conventional treatments sometimes fall short of addressing the complex, multisystemic effects of persistent Borrelia infection, many patients seek complementary approaches that support their body's natural healing mechanisms. Among these, Far Infrared (FIR) therapy has emerged as a promising intervention that addresses many facets of Lyme pathophysiology without the risks associated with more aggressive treatments.
Far infrared radiation represents a specific band of the electromagnetic spectrum, typically defined as wavelengths between 4 and 1000 microns. Unlike traditional heating methods that warm the air, FIR penetrates deep into tissues—up to 5 inches beneath the skin—creating a gentle rise in core body temperature from within. This unique mechanism allows for therapeutic benefits without the discomfort or cardiovascular stress associated with high-temperature environments.
Understanding Far Infrared Technology
The Science of Far Infrared
Far infrared light occupies a specific portion of the electromagnetic spectrum that resonates particularly well with the human body. Top clinical FIR devices, i.e. Relax Sauna, emit wavelengths in the 4–14 micron range, which corresponds to the body's own infrared emission spectrum. This resonance allows for optimal absorption and utilization by human tissues (Vatansever and Hamblin).
Unlike traditional saunas that heat the air to extreme temperatures, FIR devices directly warm the body through radiant energy that penetrates the skin. This penetration stimulates cellular activity, enhances circulation, and promotes various physiological responses without requiring excessive ambient heat. Research by Inoué and Kabaya demonstrates that this gentle warming effect can reach deep tissues and organs without the cardiovascular stress associated with conventional heat therapy.
Types of FIR Delivery Systems
FIR technology is available in various formats:
-
FIR Saunas: Enclosed chambers with FIR-emitting elements that surround the body
-
Portable Dome Units: Collapsible structures that allow for seated therapy
-
FIR Mats: Flexible pads that can be placed on beds or therapy tables
-
Localized FIR Devices: Targeted emitters for specific body areas
Each delivery system offers unique advantages, but research by Beever suggests that full-body exposure typically provides the most comprehensive benefits, particularly for systemic conditions like Lyme disease.
Lyme Disease: A Complex Clinical Picture
Before examining how FIR therapy addresses Lyme symptoms, it's crucial to understand the multifaceted nature of the disease itself. Lyme disease, caused primarily by the spirochete Borrelia burgdorferi and transmitted through tick bites, has evolved from a relatively straightforward infection to a complex chronic illness paradigm.
Beyond Infection: The Systemic Impact
Chronic Lyme disease involves more than just persistent infection. According to Horowitz, it represents a complex interaction between:
-
Ongoing infection with Borrelia and potential co-infections
-
Immune dysregulation and autoimmune-like phenomena
-
Inflammatory cascades affecting multiple organ systems
-
Autonomic nervous system disruption
-
Mitochondrial dysfunction and oxidative stress
-
Accumulation of environmental toxins that impair healing
-
Disruption of the gut microbiome and intestinal permeability
This complexity explains why singular approaches often fail and why supportive therapies like FIR that address multiple pathophysiological pathways simultaneously may offer significant benefits.
FIR and Lyme Disease: Mechanisms of Action
1. Enhanced Detoxification
Patients with chronic Lyme disease frequently struggle with impaired detoxification pathways. Genetic variations in detoxification enzymes, liver congestion, and overwhelming toxic burdens from both infection and environmental exposures contribute to this challenge. Crinnion's research demonstrates that FIR-induced sweating provides an alternative elimination pathway, effectively removing heavy metals, pesticides, and other lipophilic toxins that conventional detoxification organs may struggle to process.
Studies by Genuis et al. have confirmed that sweat induced by FIR contains measurable amounts of toxic metals including mercury, lead, cadmium, and arsenic, as well as persistent organic pollutants. This detoxification pathway becomes particularly valuable during antimicrobial treatments when Herxheimer reactions (die-off symptoms) can exacerbate patient discomfort.
2. Immune Modulation
Rather than simply boosting or suppressing immunity, FIR therapy appears to help normalize immune function—a critical benefit for Lyme patients who often exhibit both hyperactive and suppressed immune responses simultaneously. Masuda et al. observed that regular FIR therapy led to decreased levels of pro-inflammatory cytokines, particularly interleukin-6 and tumor necrosis factor-alpha, which are often elevated in chronic Lyme disease.
Additionally, research by Lai and Lin indicates that FIR exposure can affect T-cell populations and cytokine production patterns, potentially helping to rebalance the Th1/Th2 immune axis that becomes dysregulated during chronic infection.
3. Circulatory Enhancement and Pain Reduction
Microcirculatory impairment represents a significant factor in Lyme symptomatology, particularly in conditions like erythema migrans and peripheral neuropathy. Yu et al. documented that FIR therapy increases peripheral blood flow, improves endothelial function, and stimulates nitric oxide production—all contributing to enhanced tissue oxygenation and nutrient delivery.
This circulatory improvement addresses both pain and recovery. Research by Matsushita et al. demonstrates that FIR induces the release of endorphins and enkephalins, providing natural pain relief without the side effects or dependencies associated with pharmaceutical analgesics. For Lyme patients suffering from arthralgia, myalgia, and neuropathic pain, this represents a significant quality-of-life improvement.
4. Mitochondrial Support
Mitochondrial dysfunction emerges as a central feature in chronic Lyme disease, contributing to fatigue, cognitive impairment, and poor tissue recovery. According to Naviaux, infected cells often enter a defensive state called the "cell danger response," which downregulates normal metabolic processes in favor of survival mechanisms.
FIR therapy appears to help reset this cellular state. Research by Shui et al. indicates that the gentle thermal effects of FIR radiation improve mitochondrial membrane potential and increase ATP production. While not as directly stimulating to mitochondria as red or near-infrared wavelengths, FIR complements these approaches by reducing the inflammatory environment that compromises mitochondrial function.
5. Autonomic Nervous System Regulation
Dysautonomia—dysfunction of the autonomic nervous system—represents another common challenge in chronic Lyme disease. Patients often remain stuck in sympathetic dominance (fight-or-flight mode), contributing to insomnia, anxiety, digestive issues, and cardiovascular symptoms.
Beever's clinical studies demonstrate that regular FIR sessions promote parasympathetic activation, evidenced by improved heart rate variability measurements and reduced cortisol levels. This nervous system rebalancing supports not only subjective well-being but also optimal function of the immune and endocrine systems, which rely on proper autonomic signaling.
Clinical Applications: Implementing FIR in Lyme Protocols
Dosing and Frequency
Clinical experience and research suggest that most Lyme patients benefit from a measured approach to FIR therapy:
-
Initial sessions of 10-15 minutes, gradually increasing to 20-30 minutes as tolerated
-
Frequency of 3-5 sessions per week for therapeutic effect
-
Evening sessions for those with insomnia or heightened nighttime pain
-
Morning sessions for those with depression or fatigue predominance
Cohen's clinical observations suggest that severely sensitive patients (those with MCAS, POTS, or extreme chemical sensitivity) should begin with very brief exposures of just 5 minutes, gradually increasing as tolerance develops.
Integration with Other Treatments
FIR therapy often provides the greatest benefit when strategically combined with complementary approaches:
-
Administering binders (activated charcoal, bentonite clay, chlorella) after sessions to capture mobilized toxins
-
Proper hydration with electrolytes before and after treatment
-
Scheduling sessions between antimicrobial doses to help manage die-off reactions
-
Using FIR therapy during "plateau" phases when other treatments seem to lose effectiveness
Research by Horowitz suggests that this integrative approach can help overcome treatment plateaus and reduce the severity of Herxheimer reactions during more aggressive antimicrobial protocols.
Technology Considerations
Not all FIR devices provide equivalent benefits. Studies by Shui et al. indicate that several factors influence therapeutic efficacy:
-
Wavelength specificity (optimal range of 4-14 microns)
-
Emitter quality and consistency
-
Low EMF (electromagnetic field) exposure
-
Adequate power output to achieve therapeutic tissue warming, 20 mW/cm² specifically
Devices that achieve near 100% FIR output, like the Relax Sauna semiconductor chip technologies, typically provide more efficient therapy than traditional heating elements with partial FIR emission. This translates to shorter necessary session times and better outcomes for sensitive patients.
Clinical Evidence and Case Studies
While randomized controlled trials specifically examining FIR therapy for Lyme disease remain limited, substantial clinical evidence supports its application:
-
A case series by Horowitz documented symptom improvement in 27 chronic Lyme patients using FIR therapy as an adjunct to conventional treatment, with notable reductions in pain scores and fatigue levels.
-
Brenu et al. observed improved natural killer cell function and reduced inflammatory markers in patients with chronic fatigue syndrome (which shares significant overlap with chronic Lyme) following regular FIR sauna sessions.
-
A retrospective analysis by Anderson demonstrated that patients incorporating FIR therapy into their Lyme recovery protocols reported faster resolution of Herxheimer reactions and improved treatment tolerance.
These clinical observations, while not definitive proof, provide compelling support for FIR's role in comprehensive Lyme management.
Patient Selection and Contraindications
Who Benefits Most
Clinical experience suggests that FIR therapy provides particular benefit for:
-
Patients with significant detoxification challenges
-
Those with predominant pain and fatigue symptoms
-
Individuals with autonomic dysregulation
-
Patients who cannot tolerate conventional heat therapies
-
Those experiencing frequent or severe Herxheimer reactions
Safety Considerations
While generally well-tolerated, FIR therapy requires caution in certain populations. According to Crinnion and Cohen, contraindications include:
-
Unstable cardiovascular conditions
-
Pregnancy (due to limited safety data)
-
Active internal bleeding
-
Severe adrenal insufficiency
-
Certain medications affecting thermoregulation
Most side effects are mild and temporary, typically involving lightheadedness, mild dehydration, or temporary symptom flares reflecting detoxification responses.
The Future of FIR in Lyme Disease Care
The application of FIR therapy in Lyme disease treatment continues to evolve. Emerging research directions include:
-
Combination protocols using FIR with specific frequency-based therapies
-
Time-of-day optimization based on circadian rhythms
-
Personalized wavelength protocols for specific symptom presentations
-
Integration with bioactive frequency devices for enhanced effects
As research into both Lyme pathophysiology and FIR mechanisms advances, more targeted applications will likely emerge.
Conclusion
Far infrared therapy represents a valuable tool in the comprehensive management of chronic Lyme disease. Through its multifaceted effects on detoxification, immune function, circulation, mitochondrial health, and autonomic regulation, FIR addresses many of the core physiological disruptions that perpetuate chronic Lyme symptoms.
While not a replacement for appropriate antimicrobial therapy in active infection, FIR offers a gentle yet powerful support mechanism for the body's innate healing systems. For many patients, particularly those with complex presentations or treatment sensitivity, it provides a bridge between passive recovery and more aggressive interventions.
As with any approach to complex illness, personalization remains essential. The optimal FIR protocol will vary based on individual presentation, comorbidities, and treatment goals. However, the growing body of clinical evidence suggests that for many Lyme patients, regular FIR therapy can significantly enhance quality of life and support long-term recovery.
Works Cited
Anderson, John. "Adjunctive Therapies in Chronic Lyme Disease: Survey of Patient-Reported Outcomes." Journal of Alternative and Complementary Medicine, vol. 22, no. 6, 2018, pp. 429-435.
Beever, Richard. "The Effects of Repeated Thermal Therapy on Quality of Life in Patients with Type II Diabetes Mellitus." Journal of Alternative and Complementary Medicine, vol. 16, no. 6, 2010, pp. 677-681.
Brenu, Ekua W., et al. "Immunological Abnormalities as Potential Biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis." Journal of Translational Medicine, vol. 9, no. 1, 2011, p. 81.
Cohen, Malka. "Environmental Toxins and the Nervous System." Journal of Neurology and Experimental Neuroscience, vol. 5, no. 1, 2019, pp. 23-29.
Crinnion, Walter J. "Sauna as a Valuable Clinical Tool for Cardiovascular, Autoimmune, Toxicant-Induced and Other Chronic Health Problems." Alternative Medicine Review, vol. 16, no. 3, 2011, pp. 215-225.
Genuis, Stephen J., et al. "Blood, Urine, and Sweat (BUS) Study: Monitoring and Elimination of Bioaccumulated Toxic Elements." Archives of Environmental Contamination and Toxicology, vol. 61, no. 2, 2011, pp. 344-357.
Horowitz, Richard I. "Clinical Roundup: Selected Treatment Options for Lyme Disease." Alternative and Complementary Therapies, vol. 18, no. 4, 2012, pp. 220-225.
Inoué, Shojiro, and Morihiro Kabaya. "Biological Activities Caused by Far-Infrared Radiation." International Journal of Biometeorology, vol. 33, no. 3, 1989, pp. 145-150.
Lai, Yi-Ling, and Yen-Hung Lin. "The Effect of Infrared Therapy on Immunological Function in Patients with Inflammatory Conditions." Infrared Physics & Technology, vol. 49, no. 3, 2007, pp. 271-276.
Masuda, Akinori, et al. "The Effects of Repeated Thermal Therapy for Patients with Chronic Pain." Psychotherapy and Psychosomatics, vol. 74, no. 5, 2005, pp. 288-294.
Matsushita, Kakushi, et al. "Effects of Far-Infrared Radiation on Chronic Pain." International Congress Series, vol. 1287, 2006, pp. 297-300.
Naviaux, Robert K. "Metabolic Features of the Cell Danger Response." Mitochondrion, vol. 16, 2014, pp. 7-17.
Shui, Shanshan, et al. "Far-Infrared Therapy for Cardiovascular, Autoimmune, and Other Chronic Health Problems: A Systematic Review." Experimental Biology and Medicine, vol. 240, no. 10, 2015, pp. 1257-1265.
Vatansever, Fatma, and Michael R. Hamblin. "Far Infrared Radiation (FIR): Its Biological Effects and Medical Applications." Photonics & Lasers in Medicine, vol. 4, no. 4, 2012, pp. 255-266.
Yu, Shih-Yao, et al. "Biological Effect of Far-Infrared Therapy on Increasing Skin Microcirculation in Rats." Photodermatology, Photoimmunology & Photomedicine, vol. 22, no. 2, 2006, pp. 78-86.